TORONTO, July 22, 2024 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor’s remuneration.
For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.
About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
For further information, please contact:
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


Đề xuất
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions
AIM ImmunoTech Announces Closing of its Rights Offering
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Curaechoice and Health Benefit Alliance Partner to Deliver No-Cost Healthcare to 161,000 Members Across 42 States
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autoliv announces appointment of new CFO